TIPE Inhibits Ferroptosis in Colorectal Cancer Cells by Regulating MGST1/ALOX5

Changxiu Yan1, Shengnan Yu1, Jing Zhang2

  • 1Fujian Provincial Key Laboratory of Organ and Tissue Regeneration, School of Medicine, Organ Transplantation Institute of Xiamen University, Xiamen University, Xiamen, China.

PubMed

Insights

TIPE protein promotes colorectal cancer by inhibiting ferroptosis, a cell death pathway. It achieves this by regulating the MGST1-ALOX5 interaction, offering potential new treatment strategies.

Area of Science:

  • Oncology
  • Cell Death Mechanisms
  • Biochemistry

Background:

  • Ferroptosis, a form of regulated cell death, is crucial in cancer biology and is characterized by lipid peroxidation.
  • Microsomal glutathione transferase 1 (MGST1) plays a key role in preventing lipid peroxidation, thus resisting ferroptosis.
  • The protein TIPE is implicated in cancer progression and its role in ferroptosis regulation in colorectal cancer requires elucidation.

Purpose of the Study:

  • To investigate the mechanism by which TIPE regulates MGST1 expression and ferroptosis in colorectal cancer.
  • To determine the correlation between TIPE expression and colorectal cancer cell proliferation.
  • To explore the potential therapeutic implications of targeting the TIPE-MGST1 pathway.

Main Methods:

  • Quantitative analysis of TIPE and MGST1 expression in colorectal cancer tissues.
  • Measurement of reactive oxygen species and lipid reactive oxygen species.
  • Transmission electron microscopy for ferroptosis detection.
  • Bioinformatics analysis to assess gene expression correlations.
  • Western blotting and co-immunoprecipitation to study protein interactions and signaling pathways (e.g., ERK1/2 phosphorylation).
  • In vivo tumor formation experiments in nude mice.

Main Results:

  • TIPE expression is elevated in colorectal cancer and correlates positively with tumor cell proliferation.
  • TIPE regulates MGST1 expression by activating ERK1/2 phosphorylation.
  • TIPE-induced MGST1 binding to ALOX5 inhibits ALOX5 phosphorylation, thereby suppressing ferroptosis.
  • Inhibition of ferroptosis by TIPE promotes colorectal cancer cell proliferation.
  • Tumor formation experiments confirmed TIPE's role in promoting colorectal cancer growth by regulating ferroptosis.

Conclusions:

  • TIPE inhibits colorectal cancer ferroptosis through an interaction involving MGST1 and ALOX5.
  • This interaction leads to suppressed lipid peroxidation and promotes tumor cell proliferation.
  • Targeting the TIPE-MGST1-ALOX5 axis presents a promising strategy for colorectal cancer treatment.

Related Concept Videos

Drugs that Stabilize Microtubules01:15

Drugs that Stabilize Microtubules

Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.0K
Necrosis01:16

Necrosis

Necrosis is considered as an “accidental” or unexpected form of cell death that ends in cell lysis. The first noticeable mention of “necrosis” was in 1859 when Rudolf Virchow used this term to describe advanced tissue breakdown in his compilation titled “Cell Pathology”.
Morphological Manifestations of Necrosis
Necrotic cells show different types of morphological appearance depending on the type of tissue and infection. In coagulative necrosis, cells become...
4.3K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.5K